SCHEMBL5451457

SCHEMBL5451457

CCOC(=O)c1ccc(N2NC(=O)CC2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
HTT P42858 4/20 0.54
HPGD P15428 3/20 0.54
HSP90AA1 P07900 1/20 0.54
CACNA1B Q00975 1/20 0.54
APBA1 Q02410 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
GAA P10253 3/20 0.53
MAPK1 P28482 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
IDO1 P14902 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ESR1 P03372 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
ESR2 Q92731 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29048967 0.80 HTT (0.62) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL30533063 0.75 HTT (0.67) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL9645365 0.73 ALOX5 (0.74) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL87450 0.73 CA1 (0.83) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL7431121 0.72 HTT (0.57) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL20188098 0.72 HPGD (0.65) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL22015905 0.72 HPGD (0.65) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL4661824 0.72 MAPT (0.61) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL8302040 0.71 MAPK1 (0.65) ALDH1A1HTTHPGDHSP90AA1CACNA1B
SCHEMBL4893761 0.71 MEN1 (0.66) ALDH1A1HTTHPGDHSP90AA1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070037846-A1 Pyrazolidinedione derivatives ACTELION PHARMACEUTICALS, LTD. (CH) 2007-02-15 US disclosed
CN-1812782-A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors ACTELION PHARMACEUTICALS LTD (CH) 2006-08-02 CN disclosed
WO-2005002574-A1 PYRAZOLIDINEDIONE DERIVATIVES AND THEIR USE AS PLATELET AGGREGATION INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2005-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037846-A1 Pyrazolidinedione derivatives P2RY1, P2RY4, P2RY2 ALDH1A1 1198/4885HTT 1510/4885HPGD 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.